Possible predictors of recurrence risk of deep endometriosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To evaluate individual risk factors for recurrence of deep endometriosis (DE) on the basis of the obtained clinical, anamnestic and molecular biological data and to develop a formula for the individual recurrence risk of DE.

Materials and methods: This was a study of the clinical and anamnestic data of 200 patients with DE who underwent surgical treatment at the Department of General Surgery of the National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Moscow during the period from 2020 to 2021. Group I consisted of 80 patients with recurrent DE, and group II included 120 patients with newly diagnosed DE. All patients underwent surgical treatment followed by immunohistochemical (IHC) assessment. The most significant risk factors for the recurrence of DE were selected using binary logistic regression, and the computer model of a possible recurrence of DE was developed.

Results: The detailed study of clinical, anamnestic and IHC data of the patients revealed five risk factors for recurrence of DE, namely: the age of the patients at the time of surgery, the duration of the disease, EphA1 expression in the ectopic endometrium, protein to the VEGF receptor in the eutopic and ectopic endometrium. A mathematical model with a sensitivity of 97.3% and a specificity of 85.7% was developed on the basis of the identified risk factors; the accuracy of the mathematical model was 93.1%. The duration of the recurrence interval averaged 48 (24;72) months. The recurrence interval was significantly longer in patients with a more radical extent of surgery (3 (2;11.5) years versus 1 (1;3) years, respectively (p<0.05)). The recurrence interval was almost three times less in patients after bowel shaving compared to women after intestinal resection (2 (1;3) years versus 3 (2;11.5) years, respectively, p=0.001)). The excision of all visible endometrioid foci reduces the risk of recurrence of endometriosis.

Conclusion: The mathematical model with high sensitivity and specificity was developed on the basis of the obtained data using binary logistic regression. In order to determine the possible risks of endometriosis recurrence, it is necessary to validate the presented model which can be useful in the work of obstetrician-gynecologists.

Full Text

Restricted Access

About the authors

Daria N. Senina

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: seninadasha1995@gmail.com

graduate student of the Surgical Department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4; 119992, Moscow, Trubetskaya str., 8-2

Vladimir D. Chuprynin

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_chuprynin@oparina4.ru

PhD, Head of the Surgical Department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Alexandra V. Asaturova

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a.asaturova@gmail.com

Dr. Med. Sci., Head of the 1st Pathology Department

Russian Federation, 117997, Moscow, Oparin str., 4

Vyacheslav V. Chursin

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: v_chursin@oparina4.ru

doctor at the surgical department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

Natalya A. Buralkina

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: natalyaburalkina@yandex.ru

Dr. Med. Sci., Senior Researcher at Surgical Department

Russian Federation, 117997, Moscow, Ac. Oparin str., 4

References

  1. Abo C., Moatassim S., Marty N., Saint Ghislain M., Huet E., Bridoux V. et al. Postoperative complications after bowel endometriosis surgery by shaving, disc excision, or segmental resection: a three-arm comparative analysis of 364 consecutive cases. Fertil. Steril. 2018; 109(1): 172-8.e1. https://dx.doi.org/10.1016/j.fertnstert.2017.10.001.
  2. Singh S.S., Gude K., Perdeaux E., Gattrell W.T., Becker C.M. Surgical Outcomes in patients with endometriosis: a systematic review. J. Obstet. Gynaecol. Can. 2020; 42(7): 881-8.e11. https://dx.doi.org/10.1016/ j.jogc.2019.08.004.
  3. Zakhari A., Edwards D., Ryu M., Matelski J.J., Bougie O., Murji A. Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis. J. Minim. Invasive Gynecol. 2020; 27(7): 1503-10. https://dx.doi.org/10.1016/j.jmig.2020.05.007.
  4. Zakhari A., Delpero E., McKeown S., Tomlinson G., Bougie O., Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum. Reprod. Update. 2021; 27(1): 96-107. https://dx.doi.org/10.1093/humupd/dmaa033.
  5. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health (London). 2015; 11(5): 693-9. https://dx.doi.org/10.2217/whe.15.56.
  6. Busacca M., Chiaffarino F., Candiani M., Vignali M., Bertulessi C., Oggioni G., Parazzini F. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am. J. Obstet. Gynecol. 2006; 195(2): 426-32. https://dx.doi.org/10.1016/j.ajog.2006.01.078.
  7. Biacchiardi C.P., Piane L.D., Camanni M., Deltetto F., Delpiano E.M. et al. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod. Biomed. Online. 2011; 23(6): 740-6. https://dx.doi.org/10.1016/j.rbmo.2011.07.014.
  8. Джобава Э.М., Мандрыкина Ж.А., Логинова К.Б., Доброхотова Ю.Э. Дисменорея. Этиопатогенез, дифференциальная диагностика и терапия в практике современного акушера-гинеколога. РМЖ. Мать и дитя. 2012; 1: 28-34. [Dzhobava E.M., Mandrykina Zh.A., Loginova K.B., Dobrokhotova Yu.E. Dysmenorrhea. Etiopathogenesis, differential diagnosis and therapy in the practice of a modern obstetrician-gynecologist. Russian Journal of Woman and Child Health. 2012; (1): 28-34. (in Russian)].
  9. Борисова А.В., Козаченко А.В., Франкевич В.Е., Чаговец В.В., Кононихин А.С., Стародубцева Н.Л., Коган Е.А., Адамян Л.В. Факторы риска развития рецидива наружного генитального эндометриоза после оперативного лечения: проспективное когортное исследование. Медицинский совет. 2018; 7: 32-8. [ Borisova A.V., Kozachenko A.V., Frankevich V.E., Chagovets V.V., Kononokhin A.S., Starodubtseva N.L., Kogan E.A., Adamyan L.V. Risk factors for recurrence of external genital endometriosis after surgical treatment: prospective cohortant study. Medical Council. 2018; (7): 32-8. (in Russian)]. https://dx.doi.org/10.21518/ 2079-701X-2018-7-32-38.
  10. Makieva S., Giacomini E., Ottolina J., Sanchez A.M., Papaleo E., Viganò P. Inside the endometrial cell signaling subway: Mind the Gap(s). Int. J. Mol. Sci. 2018; 19(9): 2477. https://dx.doi.org/10.3390/ijms19092477.
  11. Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science. 1987; 238(4834): 1717-20. https://dx.doi.org/10.1126/science.2825356.
  12. Wada H., Yamamoto H., Kim C., Uemura M., Akita H., Tomimaru Y. et al. Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma. Int. J. Oncol. 2014; 45(3): 1051-8. https://dx.doi.org/10.3892/ijo.2014.2519.
  13. Yamamoto H., Tei M., Uemura M., Takemasa I., Uemura Y., Murata K. et al. Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. In.t J. Oncol. 2013; 42(2): 549-55. https://dx.doi.org/10.3892/ ijo.2012.1750.
  14. Davis S., Gale N.W., Aldrich T.H., Maisonpierre P.C., Lhotak V., Pawson T. et al. Ligands for EPH-related receptor tyrosinekinases that require membrane or clustering for activity. Science. 1994; 266(5186): 816-9. https://dx.doi.org/10.1126/science.7973638.
  15. Pasquale E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer. 2010; 10(3): 165-80. https://dx.doi.org/10.1038/nrc2806.
  16. Муфтайдинова Ш.К., Чупринин В.Д., Файзуллина Н.М., Буралкина Н.А., Щеголев А.И., Файзуллин Л.З., Оводенко Д.Л., Асатурова А.В., Серов В.Н. Экспрессия рецептора тирозинкиназы (epha2) в эндометрии у пациенток с глубоким инфильтративным эндометриозом. Акушерство и гинекология. 2020; 3: 110-4. [Muftaidinova Sh.K., Chuprynin V.D., Faizullina N.M., Buralkina N.A., Shchegolev A.I., Faizullin L.Z., Ovodenko D.L., Asaturova A.V., Serov V.N. Endometrial expression of tyrosine kinase receptor (EphA2) in patients with deep infiltrating endometriosis. Obstetrics and Gynecology. 2020; (3): 110-4. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.3.110-114.
  17. Кулаков В.И., Григорян К.В., Гаспаров А.С., Камилова Д.П., Стыгар Д.А. Восстановление репродуктивной функции у пациенток с эндометриоз- ассоциированным бесплодием после комплексного лечения. Проблемы репродукции. 1999; 2: 59-61. [Kulakov V.I., Grigoryan K.V., Gasparov A.S., Kamilova D.P., Stygar D.A. Recovery of reproductive function in patients with endometriosis-associated infertility after complex treatment. Problems of Reproduction. 1999; (2): 59-61. (in Russian)].
  18. Цицкарева Д.З., Ярмолинская М.И., Сельков С.А. Эффективность цитокинотерапии в комбинированном лечении больных с глубоким инфильтративным эндометриозом. Журнал акушерства и женских болезней. 2016; 65(спецвыпуск): 66-8. [Tsitskareva D.Z., Yarmolinskaya M.I., Selkov S.A. Efficacy of cytokine therapy in the combined treatment of patients with deep infiltrative endometriosis. Journal of Obstetrics and Women's Diseases. 2016; 65(Special issue): 66-8. (in Russian)].
  19. Somigliana E., Vigano' P., Parazzini F., Stoppelli S., Giambattista E., Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol. Oncol. 2006; 101(2): 331-41. https://dx.doi.org/10.1016/ j.ygyno.2005.11.033.
  20. Charafe-Jauffret E., Tarpin C., Bardou V.J., Bertucci F., Ginestier C., Braud A.C. et al. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. J. Pathol. 2004; 202(3): 265-73. https://dx.doi.org/10.1002/path.1515.
  21. Goetz T.G., Mamillapalli R., Taylor H.S. Low body mass index in endometriosis is promoted by hepatic metabolic gene dysregulation in mice. Biol. Reprod. 2016; 95(6): 115. https://dx.doi.org/10.1095/biolreprod.116.142877.
  22. Rowlands I.J., Hockey R., Abbott J.A., Montgomery G.W., Mishra G.D. Body mass index and the diagnosis of endometriosis: findings from a national data linkage cohort study. Obes. Res. Clin. Pract. 2022; 16(3): 235-41. https://dx.doi.org/10.1016/j.orcp.2022.04.002.
  23. Vannuccini S., Clemenza S., Rossi M., Petraglia F. Hormonal treatments for endometriosis: the endocrine background. Rev. Endocr. Metab. Disord. 2022; 23(3): 333-5. https://dx.doi.org/10.1007/s11154-021-09666-w.
  24. Porta R.P., Sangiuliano C., Cavalli A., Marques Pereira L.C.H., Masciullo L., Piacenti I. et al. Effects of breastfeeding on endometriosis-related pain: a prospective observational study. Int. J. Environ. Res. Public Health. 2021; 18(20): 10602. https://dx.doi.org/10.3390/ ijerph182010602.
  25. Liu X., Yuan L., Shen F., Zhu Z., Jiang H., Guo S.W. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet. Gynecol. 2007; 109(6): 1411-20. https://dx.doi.org/10.1097/ 01.AOG.0000265215.87717.8b.
  26. Fedele L., Bianchi S., Zanconato G., Bergamini V., Berlanda N., Carmignani L. Long-term follow-up after conservative surgery for bladder endometriosis. Fertil. Steril. 2005; 83(6): 1729-33. https://dx.doi.org/10.1016/ j.fertnstert.2004.12.047.
  27. Carmona F., Martínez-Zamora M.A., Rabanal A., Martinez-Roman S., Balasch J. Ovarian cystectomy versus laser vaporization in the treatment of ovarian endometriomas: a randomized clinical trial with a five-year follow-up. Fertil. Steril. 2011; 96(1): 251-4. https://dx.doi.org/10.1016/ j.fertnstert.2011.04.068.
  28. Tandoi I., Somigliana E., Riparini J., Ronzoni S., Vigano' P., Candiani M. High rate of endometriosis recurrence in young women. J. Pediatr. Adolesc. Gynecol. 2011; 24(6): 376-9. https://dx.doi.org/10.1016/j.jpag.2011.06.012.
  29. Gucciardo E., Sugiyama N., Lehti K. Eph - and ephrin - dependent mechanisms in tumor and stem cell dynamics. Cell. Mol. Life Sci. 2014; 71(19): 3685-710. https://dx.doi.org/10.1007/s00018-014-1633-0.
  30. Wu Y., Du Z., Mou J., Qiu X., Chen J., Cai S. et al. The functions of EphA1 receptor tyrosine kinase in several tumors. Curr. Med. Chem. 2022; 30(20): 2340-53. https://dx.doi.org/10.2174/0929867329666220820125638.
  31. Fujii H., Tatsumi K., Kosaka K., Yoshioka S., Fujiwara H., Fujii S. Eph–ephrin a system regulates murine blastocyst attachment and spreading. Dev. Dyn. 2006; 235(12): 3250-8. https://dx.doi.org/10.1002/dvdy.20977.
  32. Ieguchi K., Maru Y. Roles of EphA1/A2 and ephrin-A1 in cancer. Cancer Sci. 2019; 110(3): 841-8. https://dx.doi.org/10.1111/cas.13942.
  33. Kajiyama H., Suzuki S., Yoshihara M., Tamauchi S., Yoshikawa N., Niimi K. et al. Endometriosis and cancer. Free Radic. Biol. Med. 2019; 133: 186-92. https://dx.doi.org/10.1016/j.freeradbiomed.2018.12.015.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1

Download (61KB)
Indexing metadata
3. Fig. 2

Download (140KB)
Indexing metadata
4. Fig. 3

Download (64KB)
Indexing metadata

Copyright (c) 2023 Bionika Media